Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Itron (ITRI) Cash & Equivalents: 2009-2025

Historic Cash & Equivalents for Itron (ITRI) over the last 17 years, with Sep 2025 value amounting to $1.3 billion.

  • Itron's Cash & Equivalents rose 35.57% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 35.57%. This contributed to the annual value of $1.1 billion for FY2024, which is 248.04% up from last year.
  • Latest data reveals that Itron reported Cash & Equivalents of $1.3 billion as of Q3 2025, which was up 8.80% from $1.2 billion recorded in Q2 2025.
  • In the past 5 years, Itron's Cash & Equivalents registered a high of $1.3 billion during Q3 2025, and its lowest value of $162.6 million during Q4 2021.
  • Its 3-year average for Cash & Equivalents is $720.0 million, with a median of $920.6 million in 2024.
  • As far as peak fluctuations go, Itron's Cash & Equivalents tumbled by 67.81% in 2021, and later spiked by 295.49% in 2024.
  • Itron's Cash & Equivalents (Quarterly) stood at $162.6 million in 2021, then grew by 24.25% to $202.0 million in 2022, then skyrocketed by 49.52% to $302.0 million in 2023, then surged by 248.04% to $1.1 billion in 2024, then spiked by 35.57% to $1.3 billion in 2025.
  • Its Cash & Equivalents was $1.3 billion in Q3 2025, compared to $1.2 billion in Q2 2025 and $1.1 billion in Q1 2025.